Clinical trials
Phase 1 Neurologic Manifestations trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Institute for Neurodegenerative Disorders | 2 |
| Molecular NeuroImaging | 2 |
| Wake Forest University Health Sciences | 2 |
| Abington Memorial Hospital | 1 |
| Case Comprehensive Cancer Center | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Medical University of South Carolina | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Northwestern Memorial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurologic Manifestations | 20 |
| Alzheimer Disease | 3 |
| Neoplasms | 3 |
| Stroke | 3 |
| Brain Neoplasms | 2 |
| Mental Disorders | 2 |
| Multiple Sclerosis | 2 |
| Rare Diseases | 2 |
| Autonomic Nervous System Diseases | 1 |
| Brain Concussion | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.